PMID: 823030Jan 1, 1975Paper

Comparison of the pharmacokinetics of glipizide and glibenclamide in man

European Journal of Clinical Pharmacology
L BalantG R Zahnd


Four subjects received 5 mg 14C-glipizide orally, 3 subjects 1 mg intravenously and 2 subjects 5 mg 14C-glibenclamide orally. Plasma levels of radioactivity, and urinary and faecal excretion were measured. For both drugs the disappearance of radioactivity from plasma followed complex kinetics and the apparent half-lives increased steadily with time. The two sulfonylureas were extensively metabolized and were excreted in the urine as hydroxylated or conjugated metabolites. The effects of both drugs on blood glucose and immunoreactive insulin were comparable. The findings are compared with other published results.


Feb 1, 1973·The Journal of Clinical Pharmacology and New Drugs·L M FuccellaG Valzelli
Jul 6, 1971·Annals of the New York Academy of Sciences·M Gibaldi
Sep 1, 1969·Clinical Pharmacology and Therapeutics·J T Doluisio, L W Dittert
Jul 1, 1963·The Biochemical Journal·C N HALES, P J RANDLE
Jan 26, 1963·Lancet·C N HALES, P J RANDLE
May 1, 1963·Clinica Chimica Acta; International Journal of Clinical Chemistry·R ZENDER


Dec 1, 1989·Journal of Clinical Pharmacology·W A KradjanF J Wood
Oct 1, 1994·Journal of Clinical Pharmacology·W A KradjanF C Wood
Jan 1, 1977·European Journal of Clinical Pharmacology·L BalantJ Fabre
Oct 1, 1980·European Journal of Clinical Pharmacology·E Wåhlin-BollB Scherstén
Jan 1, 1981·European Journal of Clinical Pharmacology·E MaggiG Valzelli
Oct 15, 1985·Clinica Chimica Acta; International Journal of Clinical Chemistry·N A RoachR J Elin
Jun 1, 1990·British Journal of Clinical Pharmacology·S W CoppackA V Rodgers
Sep 1, 1990·British Journal of Clinical Pharmacology·M L Dahl-PuustinenI Wikström
Oct 1, 1995·Journal of Clinical Pharmacy and Therapeutics·T RydbergA Melander
Oct 1, 1991·Diabetic Medicine : a Journal of the British Diabetic Association·K AsplundB Lundman
Jun 5, 2012·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Lauro Figueroa-ValverdeGraciela Ancona-Leon
Oct 1, 1991·American Journal of Obstetrics and Gynecology·B D ElliottR F Johnson
Apr 28, 2007·Biochemical Pharmacology·Olga L ZharikovaMahmoud S Ahmed
Oct 3, 2006·Biochemical Pharmacology·Selvan RavindranMahmoud S Ahmed
Jul 1, 1982·British Journal of Clinical Pharmacology·P J MorrisonV A John
Jul 9, 2002·Seminars in Perinatology·Oded Langer
Feb 1, 1981·The American Journal of Medicine·T G Skillman, J M Feldman
Nov 11, 2016·Journal of Hazardous Materials·Marta MarkiewiczWojciech Mrozik
Jul 1, 1983·Human Toxicology·A H Stead, A C Moffat
Jan 1, 1985·The Diabetes Educator·D E Baker, R K Campbell
Oct 1, 1993·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·R JochemsenM Lupart
Nov 1, 1993·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·B EiermannU Breyer-Pfaff
Jan 1, 1980·Acta Medica Scandinavica·G SartorE Wåhlin-Boll

Related Concepts

Blood Glucose
Intravenous Injections
Intestinal Absorption
Sulfonylurea Compounds

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Archaeal RNA Polymerase

Archaeal RNA polymerases are most similar to eukaryotic RNA polymerase II but require the support of only two archaeal general transcription factors, TBP (TATA-box binding protein) and TFB (archaeal homologue of the eukaryotic general transcription factor TFIIB) to initiate basal transcription. Here is the latest research on archaeal RNA polymerases.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.